Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus.
1982355 citationsJorge Alcocer‐Varela, D Alarcón-SegoviaJournal of Clinical Investigationprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by D Alarcón-Segovia
Since
Specialization
Citations
This map shows the geographic impact of D Alarcón-Segovia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Alarcón-Segovia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Alarcón-Segovia more than expected).
Fields of papers citing papers by D Alarcón-Segovia
This network shows the impact of papers produced by D Alarcón-Segovia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Alarcón-Segovia. The network helps show where D Alarcón-Segovia may publish in the future.
Co-authorship network of co-authors of D Alarcón-Segovia
This figure shows the co-authorship network connecting the top 25 collaborators of D Alarcón-Segovia.
A scholar is included among the top collaborators of D Alarcón-Segovia based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with D Alarcón-Segovia. D Alarcón-Segovia is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Alperí, Mercedes, Nicolás González, Héctor Melín‐Aldana, et al.. (1997). HLA class I and class II alleles and haplotypes in Mexican mestizos established from serological typing of 50 families.. PubMed. 69(6). 809–18.25 indexed citations
5.
Melín‐Aldana, Héctor, Gilberto Vargas‐Alarcón, Elisa Vega‐Memije, et al.. (1995). Unrelated patients with discoid lupus erythematosus (DLE) and systemic lupus erythematosus (SLE) share the major histocompatibility complex (MHC) markers. Report of two Mexican families. European Journal of Dermatology. 5(7). 572–574.1 indexed citations
Kraus, A, et al.. (1994). Myositis in primary Sjögren's syndrome. Report of 3 cases.. PubMed. 21(4). 649–53.23 indexed citations
8.
Alcocer‐Varela, Jorge, et al.. (1994). Clinical, histopathological, immunological and fibroblast studies in 30 patients with subcutaneous injections of modelants including silicone and mineral oils.. PubMed. 46(4). 257–66.30 indexed citations
9.
Sánchez‐Guerrero, Jorge, et al.. (1990). Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature.. PubMed. 17(11). 1458–62.115 indexed citations
Ruı́z-Argüelles, Alejandro, et al.. (1989). Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin.. PubMed. 16(3). 381–3.55 indexed citations
12.
González‐Amaro, Roberto, et al.. (1984). Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial.. PubMed. 11(3). 362–4.29 indexed citations
13.
Hr, Schumacher & D Alarcón-Segovia. (1980). Osteoarthritic knees in a Pre-Columbian ceramic figure.. PubMed. 7(3). 381–2.3 indexed citations
14.
Fishbein, Eugenia, et al.. (1978). Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5(4). 384–90.3 indexed citations
15.
Díaz-Jouanen, E, et al.. (1977). Cold-reactive lymphocytotoxic antibodies in mixed connective tissue disease.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 4(1). 4–10.19 indexed citations
16.
Alarcón-Segovia, D & Eugenia Fishbein. (1975). Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. I. Differences in reactivity with Poly (U) and Poly-(A) Poly (U).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 115(1). 28–31.31 indexed citations
17.
Alarcón-Segovia, D, Eugenia Fishbein, & Sergio Estrada‐Parra. (1975). The heterogeneity of anti-DNA antibodies in systemic lupus erythematosus and other diseases.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(2). 172–7.15 indexed citations
18.
Alarcón-Segovia, D, et al.. (1970). The range and specificity of antinuclear antibodies in systemic lupus erythematosus.. PubMed Central. 6(4). 557–71.37 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.